Raras
Buscar doenças, sintomas, genes...
Síndrome de supercrescimento
ORPHA:93460CID-10 · Q87.3CID-11 · LD2CDOENÇA RARA

Grupo de síndromes causadas por defeitos congênitos genéticos que podem levar ao desenvolvimento de doenças malignas. É caracterizada por um grande tamanho corporal ou grandes partes do corpo ao nascer, ou crescimento corporal excessivo no início da infância. Exemplos representativos incluem neurofibromatose, síndrome de Beckwith-Wiedemann e síndrome de Sturge-Weber.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Grupo de síndromes causadas por defeitos congênitos genéticos que podem levar ao desenvolvimento de doenças malignas. É caracterizada por um grande tamanho corporal ou grandes partes do corpo ao nascer, ou crescimento corporal excessivo no início da infância. Exemplos representativos incluem neurofibromatose, síndrome de Beckwith-Wiedemann e síndrome de Sturge-Weber.

Pesquisas ativas
7 ensaios
19 total registrados no ClinicalTrials.gov
Publicações científicas
631 artigos
Último publicado: 2026 Apr 12
Medicamentos
9 registrados
DASIGLUCAGON, MIRANSERTIB, OCTREOTIDE ACETATE

Tem tratamento?

9 medicamentos registrados
Ver detalhes, fases e interações →
DASIGLUCAGONMIRANSERTIBOCTREOTIDE ACETATEOCTREOTIDEALPELISIBEVEROLIMUSSIROLIMUSGLUCAGONAVEXITIDE
🏥
SUS: Cobertura mínimaScore: 15%
CID-10: Q87.3
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (5)
0202010503
Cariótipo — bandas G, Q ou Rgenetic_test
0202010600
Pesquisa de microdeleções/microduplicações por FISHlab_test
0202010694
Sequenciamento completo do exoma (WES)rehabilitation
0202010260
Dosagem de alfa-fetoproteína
0301070040
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🦴
Ossos e articulações
105 sintomas
😀
Face
65 sintomas
🧠
Neurológico
59 sintomas
📏
Crescimento
54 sintomas
🧬
Pele e cabelo
44 sintomas
🫃
Digestivo
37 sintomas

+ 330 sintomas em outras categorias

Características mais comuns

Concentração diminuída de carnitina circulante
Tolerância anormal à glicose oral
Diabetes mellitus tipo 1
Adenoma de células basais salivar
Canal auditivo interno estreito
Trombose arterial
863sintomas
Sem dados (863)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 863 características clínicas mais associadas, ordenadas por frequência.

Concentração diminuída de carnitina circulanteDecreased circulating carnitine concentration
Tolerância anormal à glicose oralAbnormal oral glucose tolerance
Diabetes mellitus tipo 1Type I diabetes mellitus
Adenoma de células basais salivarSalivary basal cell adenoma
Canal auditivo interno estreitoNarrow internal auditory canal

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico631PubMed
Últimos 10 anos200publicações
Pico202239 papers
Linha do tempo
2026Hoje · 2026🧪 1994Primeiro ensaio clínico📈 2022Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

33 genes identificados com associação a esta condição.

CCND2G1/S-specific cyclin-D2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Regulatory component of the cyclin D2-CDK4 (DC) complex that phosphorylates and inhibits members of the retinoblastoma (RB) protein family including RB1 and regulates the cell-cycle during G(1)/S transition (PubMed:18827403, PubMed:8114739). Phosphorylation of RB1 allows dissociation of the transcription factor E2F from the RB/E2F complex and the subsequent transcription of E2F target genes which are responsible for the progression through the G(1) phase (PubMed:18827403, PubMed:8114739). Hypoph

LOCALIZAÇÃO

NucleusCytoplasmNucleus membrane

VIAS BIOLÓGICAS (1)
Cyclin D associated events in G1
MECANISMO DE DOENÇA

Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3

A syndrome characterized by megalencephaly, ventriculomegaly that may lead to hydrocephalus, and polymicrogyria; polydactyly may also be seen. There is considerable phenotypic similarity between this disorder and the megalencephaly-capillary malformation syndrome.

OUTRAS DOENÇAS (2)
megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome
HGNC:1583UniProt:P30279
GPC4Glypican-4Candidate gene tested inAltamente restrito
FUNÇÃO

Cell surface proteoglycan that bears heparan sulfate. May be involved in the development of kidney tubules and of the central nervous system (By similarity)

LOCALIZAÇÃO

Cell membraneSecreted, extracellular space

VIAS BIOLÓGICAS (1)
Glycosaminoglycan-protein linkage region biosynthesis
MECANISMO DE DOENÇA

Keipert syndrome

An X-linked recessive syndrome characterized by craniofacial and digital abnormalities. Clinical features include a prominent forehead, a flat midface, hypertelorism, a broad nose, downturned corners of mouth, and widening of all distal phalanges. Additional variable features are cognitive impairment and sensorineural deafness.

EXPRESSÃO TECIDUAL(Ubíquo)
Esôfago - Muscular
65.5 TPM
Esôfago - Junção
59.2 TPM
Aorta
57.7 TPM
Artéria tibial
52.8 TPM
Cólon sigmoide
44.6 TPM
OUTRAS DOENÇAS (2)
Keipert syndromeSimpson-Golabi-Behmel syndrome
HGNC:4452UniProt:O75487
HERC1Probable E3 ubiquitin-protein ligase HERC1Candidate gene tested inAltamente restrito
FUNÇÃO

Involved in membrane trafficking via some guanine nucleotide exchange factor (GEF) activity and its ability to bind clathrin. Acts as a GEF for Arf and Rab, by exchanging bound GDP for free GTP. Binds phosphatidylinositol 4,5-bisphosphate, which is required for GEF activity. May also act as a E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates

LOCALIZAÇÃO

MembraneCytoplasm, cytosolGolgi apparatus

VIAS BIOLÓGICAS (1)
Antigen processing: Ubiquitination & Proteasome degradation
MECANISMO DE DOENÇA

Macrocephaly, dysmorphic facies, and psychomotor retardation

An autosomal recessive syndrome characterized by large head and somatic overgrowth, intellectual disability, and facial dysmorphism. Seizures, hypotonia and ataxic gait are observed in some patients.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
35.4 TPM
Cerebelo
33.5 TPM
Linfócitos
26.3 TPM
Útero
24.9 TPM
Nervo tibial
24.6 TPM
INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (2)
macrocephaly, dysmorphic facies, and psychomotor retardationmegalencephaly-severe kyphoscoliosis-overgrowth syndrome
HGNC:4867UniProt:Q15751
HNF4AHepatocyte nuclear factor 4-alphaCandidate gene tested inAltamente restrito
FUNÇÃO

Transcriptional regulator which controls the expression of hepatic genes during the transition of endodermal cells to hepatic progenitor cells, facilitating the recruitment of RNA pol II to the promoters of target genes (PubMed:30597922). Activates the transcription of CYP2C38 (By similarity). Represses the CLOCK-BMAL1 transcriptional activity and is essential for circadian rhythm maintenance and period regulation in the liver and colon cells (PubMed:30530698)

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (2)
Nuclear Receptor transcription pathwayNephron development
MECANISMO DE DOENÇA

Maturity-onset diabetes of the young 1

A form of diabetes that is characterized by an autosomal dominant mode of inheritance, onset in childhood or early adulthood (usually before 25 years of age), a primary defect in insulin secretion and frequent insulin-independence at the beginning of the disease.

EXPRESSÃO TECIDUAL(Tecido-específico)
Fígado
55.4 TPM
Cólon transverso
33.0 TPM
Intestino delgado
30.7 TPM
Rim - Córtex
11.4 TPM
Pâncreas
5.6 TPM
OUTRAS DOENÇAS (7)
maturity-onset diabetes of the young type 1Fanconi renotubular syndrome 4 with maturity-onset diabetes of the youngmonogenic diabetesatypical Fanconi syndrome-neonatal hyperinsulinism syndrome
HGNC:5024UniProt:P41235
AGGF1Angiogenic factor with G patch and FHA domains 1Candidate gene tested inTolerante
FUNÇÃO

Promotes angiogenesis and the proliferation of endothelial cells. Able to bind to endothelial cells and promote cell proliferation, suggesting that it may act in an autocrine fashion

LOCALIZAÇÃO

CytoplasmSecreted

VIAS BIOLÓGICAS (1)
Signaling by BRAF and RAF1 fusions
INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (1)
angioosteohypertrophic syndrome
HGNC:24684UniProt:Q8N302
UCP2Dicarboxylate carrier SLC25A8Candidate gene tested inTolerante
FUNÇÃO

Antiporter that exports dicarboxylate intermediates of the Krebs cycle in exchange for phosphate plus a proton across the inner membrane of mitochondria, a process driven by mitochondrial motive force with an overall impact on glycolysis, glutaminolysis and glutathione-dependent redox balance. Continuous export of oxaloacetate and related four-carbon dicarboxylates from mitochondrial matrix into the cytosol negatively regulates the oxidation of acetyl-CoA substrates via the Krebs cycle, lowering

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (1)
The fatty acid cycling model
EXPRESSÃO TECIDUAL(Ubíquo)
Baço
245.1 TPM
Linfócitos
189.5 TPM
Sangue
175.4 TPM
Pulmão
68.6 TPM
Tireoide
67.7 TPM
OUTRAS DOENÇAS (1)
hyperinsulinism due to UCP2 deficiency
HGNC:12518UniProt:P55851
PTENPhosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTENCandidate gene tested inRestrito
FUNÇÃO

Dual-specificity protein phosphatase, dephosphorylating tyrosine-, serine- and threonine-phosphorylated proteins (PubMed:9187108, PubMed:9256433, PubMed:9616126). Also functions as a lipid phosphatase, removing the phosphate in the D3 position of the inositol ring of PtdIns(3,4,5)P3/phosphatidylinositol 3,4,5-trisphosphate, PtdIns(3,4)P2/phosphatidylinositol 3,4-diphosphate and PtdIns3P/phosphatidylinositol 3-phosphate with a preference for PtdIns(3,4,5)P3 (PubMed:16824732, PubMed:26504226, PubM

LOCALIZAÇÃO

CytoplasmNucleusNucleus, PML bodyCell projection, dendritic spinePostsynaptic densitySecreted

VIAS BIOLÓGICAS (10)
Synthesis of PIPs at the plasma membraneDownstream TCR signalingNegative regulation of the PI3K/AKT networkTP53 Regulates Metabolic GenesSynthesis of IP3 and IP4 in the cytosol
MECANISMO DE DOENÇA

Cowden syndrome 1

An autosomal dominant hamartomatous polyposis syndrome with age-related penetrance. Cowden syndrome is characterized by hamartomatous lesions affecting derivatives of ectodermal, mesodermal and endodermal layers, macrocephaly, facial trichilemmomas (benign tumors of the hair follicle infundibulum), acral keratoses, papillomatous papules, and elevated risk for development of several types of malignancy, particularly breast carcinoma in women and thyroid carcinoma in both men and women. Colon cancer and renal cell carcinoma have also been reported. Hamartomas can be found in virtually every organ, but most commonly in the skin, gastrointestinal tract, breast and thyroid.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
62.5 TPM
Cervix Ectocervix
62.4 TPM
Cervix Endocervix
59.7 TPM
Fallopian Tube
51.0 TPM
Cérebro - Hemisfério cerebelar
49.1 TPM
OUTRAS DOENÇAS (19)
Cowden syndrome 1prostate cancer, hereditaryPTEN hamartoma tumor syndromemacrocephaly-autism syndrome
HGNC:9588UniProt:P60484
HNF1AHepatocyte nuclear factor 1-alphaCandidate gene tested inAltamente restrito
FUNÇÃO

Transcriptional activator that regulates the tissue specific expression of multiple genes, especially in pancreatic islet cells and in liver (By similarity). Binds to the inverted palindrome 5'-GTTAATNATTAAC-3' (PubMed:10966642, PubMed:12453420). Activates the transcription of CYP1A2, CYP2E1 and CYP3A11 (By similarity) (Microbial infection) Plays a crucial role for hepatitis B virus gene transcription and DNA replication. Mechanistically, synergistically cooperates with NR5A2 to up-regulate the

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (1)
Regulation of gene expression in beta cells
MECANISMO DE DOENÇA

Hepatic adenomas familial

Rare benign liver tumors of presumable epithelial origin that develop in an otherwise normal liver. Hepatic adenomas may be single or multiple. They consist of sheets of well-differentiated hepatocytes that contain fat and glycogen and can produce bile. Bile ducts or portal areas are absent. Kupffer cells, if present, are reduced in number and are non-functional. Conditions associated with adenomas are insulin-dependent diabetes mellitus and glycogen storage diseases (types 1 and 3).

EXPRESSÃO TECIDUAL(Tecido-específico)
Fígado
8.7 TPM
Intestino delgado
6.3 TPM
Rim - Córtex
5.3 TPM
Cólon transverso
4.3 TPM
Estômago
4.1 TPM
OUTRAS DOENÇAS (11)
maturity-onset diabetes of the young type 3nonpapillary renal cell carcinomahepatic adenomas, familialtype 1 diabetes mellitus 20
HGNC:11621UniProt:P20823
IDH2Isocitrate dehydrogenase [NADP], mitochondrialCandidate gene tested inAltamente restrito
FUNÇÃO

Plays a role in intermediary metabolism and energy production (PubMed:19228619, PubMed:22416140). It may tightly associate or interact with the pyruvate dehydrogenase complex (PubMed:19228619, PubMed:22416140)

LOCALIZAÇÃO

Mitochondrion

VIAS BIOLÓGICAS (4)
Citric acid cycle (TCA cycle)Maturation of TCA enzymes and regulation of TCA cycleMitochondrial protein degradationTranscriptional activation of mitochondrial biogenesis
MECANISMO DE DOENÇA

D-2-hydroxyglutaric aciduria 2

A neurometabolic disorder causing developmental delay, epilepsy, hypotonia, and dysmorphic features. Both a mild and a severe phenotype exist. The severe phenotype is homogeneous and is characterized by early infantile-onset epileptic encephalopathy and cardiomyopathy. The mild phenotype has a more variable clinical presentation. Diagnosis is based on the presence of an excess of D-2-hydroxyglutaric acid in the urine.

EXPRESSÃO TECIDUAL(Ubíquo)
Músculo esquelético
442.8 TPM
Coração - Ventrículo esquerdo
311.5 TPM
Rim - Medula
273.8 TPM
Linfócitos
186.0 TPM
Fígado
184.7 TPM
OUTRAS DOENÇAS (13)
d-2-hydroxyglutaric aciduria 2anaplastic oligodendrogliomagemistocytic astrocytomaoligoastrocytoma
HGNC:5383UniProt:P48735
IGF2Insulin-like growth factor 2Candidate gene tested inAltamente restrito
FUNÇÃO

The insulin-like growth factors possess growth-promoting activity (By similarity). Major fetal growth hormone in mammals. Plays a key role in regulating fetoplacental development. IGF2 is influenced by placental lactogen. Also involved in tissue differentiation. In adults, involved in glucose metabolism in adipose tissue, skeletal muscle and liver (Probable). Acts as a ligand for integrin which is required for IGF2 signaling (PubMed:28873464). Positively regulates myogenic transcription factor M

LOCALIZAÇÃO

Secreted

VIAS BIOLÓGICAS (1)
Platelet degranulation
MECANISMO DE DOENÇA

Silver-Russell syndrome 1

A form of Silver-Russell syndrome, a clinically heterogeneous condition characterized by severe intrauterine growth retardation, poor postnatal growth, craniofacial features such as a triangular shaped face and a broad forehead, body asymmetry, and a variety of minor malformations. The phenotypic expression changes during childhood and adolescence, with the facial features and asymmetry usually becoming more subtle with age. SRS1 is caused by epigenetic changes of DNA hypomethylation at the telomeric imprinting control region (ICR1) on chromosome 11p15, involving the H19 and IGF2 genes.

EXPRESSÃO TECIDUAL(Ubíquo)
Adipose Visceral Omentum
103.2 TPM
Fallopian Tube
96.7 TPM
Nervo tibial
89.4 TPM
Fígado
83.5 TPM
Cervix Endocervix
74.2 TPM
OUTRAS DOENÇAS (6)
Silver-Russell syndrome 3isolated hemihyperplasiaobsolete Silver-Russell syndrome due to a point mutationsilver-Russell syndrome due to 11p15 microduplication
HGNC:5466UniProt:P01344
NSD1Histone-lysine N-methyltransferase, H3 lysine-36 specificCandidate gene tested inAltamente restrito
FUNÇÃO

Histone methyltransferase that dimethylates Lys-36 of histone H3 (H3K36me2). Transcriptional intermediary factor capable of both negatively or positively influencing transcription, depending on the cellular context

LOCALIZAÇÃO

NucleusChromosome

VIAS BIOLÓGICAS (1)
PKMTs methylate histone lysines
MECANISMO DE DOENÇA

Sotos syndrome

An autosomal dominant, childhood overgrowth syndrome characterized by pre- and postnatal overgrowth, developmental delay, intellectual disability, advanced bone age, and abnormal craniofacial morphology including macrodolichocephaly with frontal bossing, frontoparietal sparseness of hair, apparent hypertelorism, downslanting palpebral fissures, and facial flushing. Common oral findings include: premature eruption of teeth; high, arched palate; pointed chin and, more rarely, prognathism.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
25.6 TPM
Cerebelo
23.7 TPM
Testículo
22.1 TPM
Linfócitos
20.8 TPM
Útero
19.6 TPM
OUTRAS DOENÇAS (4)
Sotos syndrome5q35 microduplication syndromeWeaver syndromedeletion 5q35
HGNC:14234UniProt:Q96L73
IDH1Isocitrate dehydrogenase [NADP] cytoplasmicCandidate gene tested inTolerante
FUNÇÃO

Catalyzes the NADP(+)-dependent oxidative decarboxylation of isocitrate (D-threo-isocitrate) to 2-ketoglutarate (2-oxoglutarate), which is required by other enzymes such as the phytanoyl-CoA dioxygenase (PubMed:10521434, PubMed:19935646). Plays a critical role in the generation of NADPH, an important cofactor in many biosynthesis pathways (PubMed:10521434). May act as a corneal epithelial crystallin and may be involved in maintaining corneal epithelial transparency (By similarity)

LOCALIZAÇÃO

Cytoplasm, cytosolPeroxisome

VIAS BIOLÓGICAS (3)
NADPH regenerationNFE2L2 regulating TCA cycle genesPeroxisomal protein import
MECANISMO DE DOENÇA

Glioma

Gliomas are benign or malignant central nervous system neoplasms derived from glial cells. They comprise astrocytomas and glioblastoma multiforme that are derived from astrocytes, oligodendrogliomas derived from oligodendrocytes and ependymomas derived from ependymocytes.

EXPRESSÃO TECIDUAL(Ubíquo)
Glândula adrenal
266.5 TPM
Fígado
100.4 TPM
Esôfago - Mucosa
99.8 TPM
Tecido adiposo
81.8 TPM
Próstata
77.7 TPM
OUTRAS DOENÇAS (7)
Maffucci syndromemetaphyseal chondromatosis with D-2-hydroxyglutaric aciduriaacute myeloid leukemia with multilineage dysplasiaOllier disease
HGNC:5382UniProt:O75874
ABCC8ATP-binding cassette sub-family C member 8Candidate gene tested inTolerante
FUNÇÃO

Regulator subunit of pancreatic ATP-sensitive potassium channel (KATP), playing a major role in the regulation of insulin release. In pancreatic cells, it forms KATP channels with KCNJ11; KCNJ11 forms the channel pore while ABCC8 is required for activation and regulation

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (2)
Regulation of insulin secretionATP sensitive Potassium channels
MECANISMO DE DOENÇA

Leucine-induced hypoglycemia

Rare cause of hypoglycemia and is described as a condition in which symptomatic hypoglycemia is provoked by high protein feedings. Hypoglycemia is also elicited by administration of oral or intravenous infusions of a single amino acid, leucine.

OUTRAS DOENÇAS (12)
hyperinsulinemic hypoglycemia, familial, 1diabetes mellitus, transient neonatal, 2diabetes mellitus, permanent neonatal 3hypoglycemia, leucine-induced
HGNC:59UniProt:Q09428
SUZ12Polycomb protein SUZ12Candidate gene tested inAltamente restrito
FUNÇÃO

Polycomb group (PcG) protein. Component of the PRC2 complex, which methylates 'Lys-9' (H3K9me) and 'Lys-27' (H3K27me) of histone H3, leading to transcriptional repression of the affected target gene (PubMed:15225548, PubMed:15231737, PubMed:15385962, PubMed:16618801, PubMed:17344414, PubMed:18285464, PubMed:28229514, PubMed:29499137, PubMed:31959557). The PRC2 complex may also serve as a recruiting platform for DNA methyltransferases, thereby linking two epigenetic repression systems (PubMed:123

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (10)
Regulation of PTEN gene transcriptionOxidative Stress Induced SenescenceRegulation of PD-L1(CD274) transcriptionPRC2 methylates histones and DNAActivation of anterior HOX genes in hindbrain development during early embryogenesis
EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
60.8 TPM
Testículo
33.8 TPM
Fibroblastos
29.5 TPM
Útero
26.4 TPM
Cérebro - Hemisfério cerebelar
25.4 TPM
OUTRAS DOENÇAS (3)
Imagawa-Matsumoto syndromeendometrioid stromal sarcomaWeaver syndrome
HGNC:17101UniProt:Q15022
H19Candidate gene tested inDesconhecido
LOCALIZAÇÃO

VIAS BIOLÓGICAS (1)
Loss of function of TP53 in cancer due to loss of tetramerization ability
OUTRAS DOENÇAS (6)
isolated hemihyperplasiakidney Wilms tumorsilver-Russell syndrome due to an imprinting defect of 11p15Beckwith-Wiedemann syndrome due to 11p15 microdeletion
HGNC:4713
OFD1Centriole and centriolar satellite protein OFD1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Component of the centrioles controlling mother and daughter centrioles length. Recruits to the centriole IFT88 and centriole distal appendage-specific proteins including CEP164 (By similarity). Involved in the biogenesis of the cilium, a centriole-associated function. The cilium is a cell surface projection found in many vertebrate cells required to transduce signals important for development and tissue homeostasis (PubMed:33934390). Plays an important role in development by regulating Wnt signa

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, microtubule organizing center, centrosome, centrioleCytoplasm, cytoskeleton, cilium basal bodyNucleusCytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriolar satellite

VIAS BIOLÓGICAS (8)
Recruitment of mitotic centrosome proteins and complexesLoss of proteins required for interphase microtubule organization from the centrosomeLoss of Nlp from mitotic centrosomesRegulation of PLK1 Activity at G2/M TransitionAURKA Activation by TPX2
MECANISMO DE DOENÇA

Orofaciodigital syndrome 1

A form of orofaciodigital syndrome, a group of heterogeneous disorders characterized by abnormalities in the oral cavity, face, and digits and associated phenotypic abnormalities that lead to the delineation of various subtypes. OFD1 is X-linked dominant syndrome, lethal in males. Craniofacial findings consist of facial asymmetry, hypertelorism, median cleft, or pseudocleft of the upper lip, hypoplasia of the alae nasi, oral clefts and abnormal frenulea, tongue anomalies (clefting, cysts, hamartoma), and anomalous dentition involving missing or extra teeth. Asymmetric brachydactyly and/or syndactyly of the fingers and toes occur frequently. Approximately 50% of OFD1 females have some degree of intellectual disability. Some patients have structural central nervous system anomalies such as agenesis of the corpus callosum, cerebellar agenesis, or a Dandy-Walker malformation. Patients with OFD1 can develop fibrocystic disease of the liver and pancreas, in addition to polycystic kidneys.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
47.1 TPM
Fallopian Tube
44.0 TPM
Tireoide
42.2 TPM
Cervix Endocervix
39.8 TPM
Útero
36.8 TPM
OUTRAS DOENÇAS (8)
Joubert syndrome 10orofaciodigital syndrome Iretinitis pigmentosa 23Simpson-Golabi-Behmel syndrome type 2
HGNC:2567UniProt:O75665
SLC16A1Monocarboxylate transporter 1Disease-causing germline mutation(s) inRestrito
FUNÇÃO

Bidirectional proton-coupled monocarboxylate transporter (PubMed:12946269, PubMed:32946811, PubMed:33333023). Catalyzes the rapid transport across the plasma membrane of many monocarboxylates such as lactate, pyruvate, acetate and the ketone bodies acetoacetate and beta-hydroxybutyrate, and thus contributes to the maintenance of intracellular pH (PubMed:12946269, PubMed:33333023). The transport direction is determined by the proton motive force and the concentration gradient of the substrate mon

LOCALIZAÇÃO

Cell membraneBasolateral cell membraneApical cell membrane

VIAS BIOLÓGICAS (3)
Aspirin ADMEProton-coupled monocarboxylate transportBasigin interactions
MECANISMO DE DOENÇA

Symptomatic deficiency in lactate transport

Deficiency of lactate transporter may result in an acidic intracellular environment created by muscle activity with consequent degeneration of muscle and release of myoglobin and creatine kinase. This defect might compromise extreme performance in otherwise healthy individuals.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
63.2 TPM
Linfócitos
42.4 TPM
Testículo
38.0 TPM
Cólon sigmoide
36.8 TPM
Cólon transverso
32.2 TPM
OUTRAS DOENÇAS (3)
ketoacidosis due to monocarboxylate transporter-1 deficiencymetabolic myopathy due to lactate transporter defectexercise-induced hyperinsulinism
HGNC:10922UniProt:P53985
GCKMitogen-activated protein kinase kinase kinase kinase 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Serine/threonine-protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Acts as a MAPK kinase kinase kinase (MAP4K) and is an upstream activator of the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway and to a lesser extent of the p38 MAPKs signaling pathway. Required for the efficient activation of JNKs by TRAF6-dependent stimuli, including pathogen-associated molecular patterns (PAMPs) such as polyinosine-polycytidi

LOCALIZAÇÃO

CytoplasmBasolateral cell membraneGolgi apparatus membrane

VIAS BIOLÓGICAS (5)
GlycolysisRegulation of gene expression in beta cellsRegulation of Glucokinase by Glucokinase Regulatory ProteinDefective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
EXPRESSÃO TECIDUAL(Tecido-específico)
Pituitária
34.5 TPM
Cérebro - Hemisfério cerebelar
7.2 TPM
Cerebelo
7.1 TPM
Hipotálamo
6.5 TPM
Coração - Átrio
3.1 TPM
OUTRAS DOENÇAS (7)
type 2 diabetes mellitusmaturity-onset diabetes of the young type 2permanent neonatal diabetes mellitus 1monogenic diabetes
HGNC:4195UniProt:Q12851
KCNQ1OT1Disease-causing germline mutation(s) inDesconhecido
LOCALIZAÇÃO

OUTRAS DOENÇAS (3)
Beckwith-Wiedemann syndromeisolated hemihyperplasiaBeckwith-Wiedemann syndrome due to imprinting defect of 11p15
HGNC:6295
CDKN1CCyclin-dependent kinase inhibitor 1CDisease-causing germline mutation(s) inModerado
FUNÇÃO

Potent tight-binding inhibitor of several G1 cyclin/CDK complexes (cyclin E-CDK2, cyclin D2-CDK4, and cyclin A-CDK2) and, to lesser extent, of the mitotic cyclin B-CDC2. Negative regulator of cell proliferation. May play a role in maintenance of the non-proliferative state throughout life

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (2)
Cyclin D associated events in G1Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)
MECANISMO DE DOENÇA

Beckwith-Wiedemann syndrome

A disorder characterized by anterior abdominal wall defects including exomphalos (omphalocele), pre- and postnatal overgrowth, and macroglossia. Additional less frequent complications include specific developmental defects and a predisposition to embryonal tumors.

OUTRAS DOENÇAS (5)
IMAGe syndromeBeckwith-Wiedemann syndromeobsolete Silver-Russell syndrome due to a point mutationintrauterine growth restriction-short stature-early adult-onset diabetes syndrome
HGNC:1786UniProt:P49918
AKT3RAC-gamma serine/threonine-protein kinaseDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

AKT3 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis. This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates. Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported. AKT3 is the least studied AKT isoform. It plays an impo

LOCALIZAÇÃO

NucleusCytoplasmMembrane

VIAS BIOLÓGICAS (5)
CD28 dependent PI3K/Akt signalingVEGFR2 mediated vascular permeabilityPIP3 activates AKT signalingNegative regulation of the PI3K/AKT networkG beta:gamma signalling through PI3Kgamma
OUTRAS DOENÇAS (4)
megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2obsolete cerebral malformationhemimegalencephalymegalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome
HGNC:393UniProt:Q9Y243
KCNJ11ATP-sensitive inward rectifier potassium channel 11Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Inward rectifier potassium channel that forms the pore of ATP-sensitive potassium channels (KATP), regulating potassium permeability as a function of cytoplasmic ATP and ADP concentrations in many different cells (PubMed:29286281, PubMed:34815345). Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it. Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is

LOCALIZAÇÃO

Membrane

VIAS BIOLÓGICAS (6)
Ion homeostasisABC-family proteins mediated transportDefective ABCC9 causes CMD10, ATFB12 and Cantu syndromeDefective ABCC8 can cause hypo- and hyper-glycemiasRegulation of insulin secretion
MECANISMO DE DOENÇA

Hyperinsulinemic hypoglycemia, familial, 2

A form of hyperinsulinemic hypoglycemia, a clinically and genetically heterogeneous disorder characterized by inappropriate insulin secretion from the pancreatic beta-cells in the presence of low blood glucose levels. HHF2 is a common cause of persistent hypoglycemia in infancy. Unless early and aggressive intervention is undertaken, brain damage from recurrent episodes of hypoglycemia may occur. HHF2 inheritance can be autosomal dominant or autosomal recessive.

EXPRESSÃO TECIDUAL(Ubíquo)
Músculo esquelético
87.1 TPM
Cerebelo
37.4 TPM
Cérebro - Hemisfério cerebelar
36.8 TPM
Córtex cerebral
14.0 TPM
Brain Frontal Cortex BA9
13.9 TPM
OUTRAS DOENÇAS (12)
maturity-onset diabetes of the young type 13diabetes mellitus, permanent neonatal 2hyperinsulinemic hypoglycemia, familial, 2diabetes mellitus, transient neonatal, 3
HGNC:6257UniProt:Q14654
GPC3Glypican-3Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Cell surface proteoglycan (PubMed:14610063). Negatively regulates the hedgehog signaling pathway when attached via the GPI-anchor to the cell surface by competing with the hedgehog receptor PTC1 for binding to hedgehog proteins (By similarity). Binding to the hedgehog protein SHH triggers internalization of the complex by endocytosis and its subsequent lysosomal degradation (By similarity). Positively regulates the canonical Wnt signaling pathway by binding to the Wnt receptor Frizzled and stimu

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (2)
Post-translational protein phosphorylationRegulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
MECANISMO DE DOENÇA

Simpson-Golabi-Behmel syndrome 1

A condition characterized by pre- and postnatal overgrowth (gigantism), facial dysmorphism and a variety of inconstant visceral and skeletal malformations. Characteristic dysmorphic features include macrocephaly with coarse, distinctive facies with a large protruding jaw, broad nasal bridge and cleft palate. Cardiac defects are frequent.

EXPRESSÃO TECIDUAL(Ubíquo)
Pulmão
201.3 TPM
Tecido adiposo
146.7 TPM
Nervo tibial
141.8 TPM
Mama
95.2 TPM
Rim - Medula
86.6 TPM
OUTRAS DOENÇAS (4)
Wilms tumor 1Simpson-Golabi-Behmel syndrome type 1kidney Wilms tumorSimpson-Golabi-Behmel syndrome
HGNC:4451UniProt:P51654
EZH2Histone-lysine N-methyltransferase EZH2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Catalytic subunit of the PRC2/EED-EZH2 complex, a Polycomb group (PcG) complex that methylates 'Lys-9' (H3K9me) and 'Lys-27' (H3K27me) of histone H3, leading to transcriptional repression of the affected target gene (PubMed:14532106, PubMed:15225548, PubMed:15385962, PubMed:16618801, PubMed:16936726, PubMed:17344414, PubMed:22323599, PubMed:24474760, PubMed:26581166, PubMed:30026490, PubMed:30923826). Able to mono-, di- and trimethylate 'Lys-27' of histone H3 to form H3K27me1, H3K27me2 and H3K27

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (10)
Regulation of PTEN gene transcriptionOxidative Stress Induced SenescenceRegulation of PD-L1(CD274) transcriptionPRC2 methylates histones and DNAActivation of anterior HOX genes in hindbrain development during early embryogenesis
MECANISMO DE DOENÇA

Weaver syndrome

A syndrome of accelerated growth and osseous maturation, unusual craniofacial appearance, hoarse and low-pitched cry, and hypertonia with camptodactyly. Distinguishing features of Weaver syndrome include broad forehead and face, ocular hypertelorism, prominent wide philtrum, micrognathia, deep horizontal chin groove, and deep-set nails. In addition, carpal bone development is advanced over the rest of the hand.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
54.7 TPM
Testículo
41.4 TPM
Esôfago - Mucosa
16.0 TPM
Skin Not Sun Exposed Suprapubic
14.8 TPM
Skin Sun Exposed Lower leg
14.7 TPM
OUTRAS DOENÇAS (1)
Weaver syndrome
HGNC:3527UniProt:Q15910
AKT1RAC-alpha serine/threonine-protein kinaseDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis (PubMed:11882383, PubMed:15526160, PubMed:15861136, PubMed:21432781, PubMed:21620960, PubMed:31204173). This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates (PubMed:11882383, PubMed:15526160, PubMed:21432781, PubMed:21620960, PubMe

LOCALIZAÇÃO

CytoplasmNucleusCell membraneMitochondrion intermembrane space

VIAS BIOLÓGICAS (7)
CD28 dependent PI3K/Akt signalingVEGFR2 mediated vascular permeabilityPIP3 activates AKT signalingNegative regulation of the PI3K/AKT networkG beta:gamma signalling through PI3Kgamma
MECANISMO DE DOENÇA

Breast cancer

A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case.

OUTRAS DOENÇAS (7)
ovarian cancerProteus syndromehereditary breast carcinomacolorectal cancer
HGNC:391UniProt:P31749
DIS3L2DIS3-like exonuclease 2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

3'-5'-exoribonuclease that specifically recognizes RNAs polyuridylated at their 3' end and mediates their degradation. Component of an exosome-independent RNA degradation pathway that mediates degradation of both mRNAs and miRNAs that have been polyuridylated by a terminal uridylyltransferase, such as ZCCHC11/TUT4. Mediates degradation of cytoplasmic mRNAs that have been deadenylated and subsequently uridylated at their 3'. Mediates degradation of uridylated pre-let-7 miRNAs, contributing to the

LOCALIZAÇÃO

CytoplasmCytoplasm, P-body

VIAS BIOLÓGICAS (1)
Z-decay: degradation of maternal mRNAs by zygotically expressed factors
MECANISMO DE DOENÇA

Perlman syndrome

An autosomal recessive congenital overgrowth syndrome. Affected children are large at birth, are hypotonic, and show organomegaly, characteristic facial dysmorphisms (inverted V-shaped upper lip, prominent forehead, deep-set eyes, broad and flat nasal bridge, and low-set ears), renal anomalies (nephromegaly and hydronephrosis), frequent neurodevelopmental delay, and high neonatal mortality. Perlman syndrome is associated with a high risk of Wilms tumor. Histologic examination of the kidneys in affected children shows frequent nephroblastomatosis, which is a precursor lesion for Wilms tumor.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
19.9 TPM
Tireoide
15.8 TPM
Ovário
14.1 TPM
Cervix Ectocervix
13.6 TPM
Cervix Endocervix
13.5 TPM
OUTRAS DOENÇAS (2)
Perlman syndromekidney Wilms tumor
HGNC:28648UniProt:Q8IYB7
NFIXNuclear factor 1 X-typeDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (2)
RNA Polymerase III Abortive And Retractive InitiationRNA Polymerase III Transcription Termination
MECANISMO DE DOENÇA

Malan syndrome

An autosomal dominant syndrome characterized by overgrowth, advanced bone age, macrocephaly, impaired intellectual development, behavior anomalies, and dysmorphic facial features. Patients develop marfanoid habitus, with long and slender body, very low body mass, long narrow face, and arachnodactyly.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
225.6 TPM
Cerebelo
208.3 TPM
Útero
137.3 TPM
Aorta
133.0 TPM
Cervix Endocervix
114.6 TPM
INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (3)
Malan overgrowth syndromeMarshall-Smith syndrome19p13.3 microduplication syndrome
HGNC:7788UniProt:Q14938
GLUD1Glutamate dehydrogenase 1, mitochondrialDisease-causing germline mutation(s) inRestrito
FUNÇÃO

Mitochondrial glutamate dehydrogenase that catalyzes the conversion of L-glutamate into alpha-ketoglutarate. Plays a key role in glutamine anaplerosis by producing alpha-ketoglutarate, an important intermediate in the tricarboxylic acid cycle (PubMed:11032875, PubMed:11254391, PubMed:16023112, PubMed:16959573). Plays a role in insulin homeostasis (PubMed:11297618, PubMed:9571255). May be involved in learning and memory reactions by increasing the turnover of the excitatory neurotransmitter gluta

LOCALIZAÇÃO

MitochondrionEndoplasmic reticulum

VIAS BIOLÓGICAS (3)
Glutamate and glutamine metabolismTranscriptional activation of mitochondrial biogenesisMitochondrial protein degradation
MECANISMO DE DOENÇA

Hyperinsulinemic hypoglycemia, familial, 6

A form of hyperinsulinemic hypoglycemia, a clinically and genetically heterogeneous disorder characterized by inappropriate insulin secretion from the pancreatic beta-cells in the presence of low blood glucose levels. HHF6 is an autosomal dominant form characterized by hypoglycemia due to congenital hyperinsulinism combined with persistent hyperammonemia. Clinical features include loss of consciousness due to hypoglycemia, hypoglycemic seizures, and mental retardation.

EXPRESSÃO TECIDUAL(Ubíquo)
Fígado
306.2 TPM
Brain Nucleus accumbens basal ganglia
296.5 TPM
Brain Anterior cingulate cortex BA24
269.5 TPM
Brain Caudate basal ganglia
266.0 TPM
Cérebro - Amígdala
254.6 TPM
OUTRAS DOENÇAS (1)
hyperinsulinism-hyperammonemia syndrome
HGNC:4335UniProt:P00367
DICER1Endoribonuclease DicerDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Double-stranded RNA (dsRNA) endoribonuclease playing a central role in short dsRNA-mediated post-transcriptional gene silencing. Cleaves naturally occurring long dsRNAs and short hairpin pre-microRNAs (miRNA) into fragments of twenty-one to twenty-three nucleotides with 3' overhang of two nucleotides, producing respectively short interfering RNAs (siRNA) and mature microRNAs. SiRNAs and miRNAs serve as guide to direct the RNA-induced silencing complex (RISC) to complementary RNAs to degrade them

LOCALIZAÇÃO

CytoplasmCytoplasm, perinuclear region

VIAS BIOLÓGICAS (5)
MicroRNA (miRNA) biogenesisSmall interfering RNA (siRNA) biogenesistRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesisM-decay: degradation of maternal mRNAs by maternally stored factorsRegulation of MITF-M-dependent genes involved in apoptosis
MECANISMO DE DOENÇA

Pleuropulmonary blastoma

A rare pediatric intrathoracic neoplasm. The tumor arises from the lung, pleura, or both, and appears to be purely mesenchymal in phenotype. It lacks malignant epithelial elements, a feature that distinguishes it from the classic adult-type pulmonary blastoma. It arises during fetal lung development and is often part of an inherited cancer syndrome. The tumor contain both epithelial and mesenchymal cells. Early in tumorigenesis, cysts form in lung airspaces, and these cysts are lined with benign-appearing epithelium. Mesenchymal cells susceptible to malignant transformation reside within the cyst walls and form a dense layer beneath the epithelial lining. In a subset of patients, overgrowth of the mesenchymal cells produces a sarcoma, a transition that is associated with a poorer prognosis. Some patients have multilocular cystic nephroma, a benign kidney tumor.

EXPRESSÃO TECIDUAL(Ubíquo)
Nervo tibial
46.1 TPM
Tireoide
31.6 TPM
Cervix Endocervix
31.4 TPM
Útero
31.2 TPM
Ovário
30.2 TPM
OUTRAS DOENÇAS (10)
pleuropulmonary blastomaglobal developmental delay - lung cysts - overgrowth - Wilms tumor syndromegoiter, multinodular 1, with or without Sertoli-Leydig cell tumorsrhabdomyosarcoma, embryonal, 2
HGNC:17098UniProt:Q9UPY3
PIK3R2Phosphatidylinositol 3-kinase regulatory subunit betaDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Regulatory subunit of phosphoinositide-3-kinase (PI3K), a kinase that phosphorylates PtdIns(4,5)P2 (Phosphatidylinositol 4,5-bisphosphate) to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3). PIP3 plays a key role by recruiting PH domain-containing proteins to the membrane, including AKT1 and PDPK1, activating signaling cascades involved in cell growth, survival, proliferation, motility and morphology. Binds to activated (phosphorylated) protein-tyrosine kinases, through its SH2 domain,

LOCALIZAÇÃO

VIAS BIOLÓGICAS (10)
Signaling by LTK in cancerNephrin family interactionsIRS-mediated signallingTie2 SignalingDAP12 signaling
MECANISMO DE DOENÇA

Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1

A syndrome characterized by megalencephaly, hydrocephalus, and polymicrogyria; polydactyly may also be seen. There is considerable phenotypic similarity between this disorder and the megalencephaly-capillary malformation syndrome.

EXPRESSÃO TECIDUAL(Ubíquo)
Glândula adrenal
58.3 TPM
Córtex cerebral
54.6 TPM
Ovário
54.1 TPM
Brain Frontal Cortex BA9
48.7 TPM
Pituitária
47.6 TPM
OUTRAS DOENÇAS (3)
megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1obsolete cerebral malformationmegalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome
HGNC:8980UniProt:O00459
PIK3CAPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoformDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Phosphoinositide-3-kinase (PI3K) phosphorylates phosphatidylinositol (PI) and its phosphorylated derivatives at position 3 of the inositol ring to produce 3-phosphoinositides (PubMed:15135396, PubMed:23936502, PubMed:28676499). Uses ATP and PtdIns(4,5)P2 (phosphatidylinositol 4,5-bisphosphate) to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3) (PubMed:15135396, PubMed:28676499). PIP3 plays a key role by recruiting PH domain-containing proteins to the membrane, including AKT1 and PDPK1,

LOCALIZAÇÃO

VIAS BIOLÓGICAS (10)
Signaling by LTK in cancerNephrin family interactionsIRS-mediated signallingTie2 SignalingDAP12 signaling
EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
23.2 TPM
Linfócitos
22.4 TPM
Nervo tibial
21.4 TPM
Tecido adiposo
20.5 TPM
Fibroblastos
20.5 TPM
OUTRAS DOENÇAS (28)
seborrheic keratosismegalodactylyovarian cancerhepatocellular carcinoma
HGNC:8975UniProt:P42336
AKT2RAC-beta serine/threonine-protein kinaseDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Serine/threonine kinase closely related to AKT1 and AKT3. All 3 enzymes, AKT1, AKT2 and AKT3, are collectively known as AKT kinase. AKT regulates many processes including metabolism, proliferation, cell survival, growth and angiogenesis, through the phosphorylation of a range of downstream substrates. Over 100 substrates have been reported so far, although for most of them, the precise AKT kinase catalyzing the reaction was not specified. AKT regulates glucose uptake by mediating insulin-induced

LOCALIZAÇÃO

CytoplasmNucleusCell membraneEarly endosome

VIAS BIOLÓGICAS (5)
CD28 dependent PI3K/Akt signalingVEGFR2 mediated vascular permeabilityPIP3 activates AKT signalingNegative regulation of the PI3K/AKT networkG beta:gamma signalling through PI3Kgamma
OUTRAS DOENÇAS (3)
hypoinsulinemic hypoglycemia and body hemihypertrophytype 2 diabetes mellitusAKT2-related familial partial lipodystrophy
HGNC:392UniProt:P31751
HADHHydroxyacyl-coenzyme A dehydrogenase, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Mitochondrial fatty acid beta-oxidation enzyme that catalyzes the third step of the beta-oxidation cycle for medium and short-chain 3-hydroxy fatty acyl-CoAs (C4 to C10) (PubMed:10231530, PubMed:11489939, PubMed:16725361). Plays a role in the control of insulin secretion by inhibiting the activation of glutamate dehydrogenase 1 (GLUD1), an enzyme that has an important role in regulating amino acid-induced insulin secretion (By similarity). Plays a role in the maintenance of normal spermatogenesi

LOCALIZAÇÃO

Mitochondrion matrix

VIAS BIOLÓGICAS (6)
Beta oxidation of butanoyl-CoA to acetyl-CoABeta oxidation of hexanoyl-CoA to butanoyl-CoABeta oxidation of octanoyl-CoA to hexanoyl-CoABeta oxidation of decanoyl-CoA to octanoyl-CoA-CoABeta oxidation of lauroyl-CoA to decanoyl-CoA-CoA
MECANISMO DE DOENÇA

3-alpha-hydroxyacyl-CoA dehydrogenase deficiency

An autosomal recessive, metabolic disorder with various clinical presentations including hypoglycemia, hepatoencephalopathy, myopathy or cardiomyopathy, and in some cases sudden death.

EXPRESSÃO TECIDUAL(Ubíquo)
Músculo esquelético
55.6 TPM
Adipose Visceral Omentum
50.9 TPM
Coração - Ventrículo esquerdo
49.9 TPM
Tecido adiposo
48.5 TPM
Artéria tibial
45.6 TPM
OUTRAS DOENÇAS (2)
hyperinsulinemic hypoglycemia, familial, 43-hydroxyacyl-CoA dehydrogenase deficiency
HGNC:4799UniProt:Q16836

Medicamentos e terapias

DASIGLUCAGONPhase 3

Mecanismo: Glucagon receptor agonist

MIRANSERTIBPhase 2

Mecanismo: Serine/threonine-protein kinase AKT inhibitor

OCTREOTIDE ACETATEPhase 2

Mecanismo: Somatostatin receptor agonist

OCTREOTIDEPhase 2

Mecanismo: Somatostatin receptor agonist

ALPELISIBPhase 2

Mecanismo: PI3-kinase p110-alpha subunit inhibitor

EVEROLIMUSPhase 2

Mecanismo: FK506-binding protein 1A inhibitor

SIROLIMUSPhase 2

Mecanismo: FK506-binding protein 1A inhibitor

GLUCAGONPhase 2

Mecanismo: Glucagon receptor agonist

AVEXITIDEPhase 1

Mecanismo: Glucagon-like peptide 1 receptor antagonist

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

545 variantes patogênicas registradas no ClinVar.

🧬 CCND2: GRCh38/hg38 12p13.33-11.1(chr12:64621-34650483)x3 ()
🧬 CCND2: GRCh38/hg38 12p13.33-q13.12(chr12:82453-49847230)x3 ()
🧬 CCND2: GRCh37/hg19 12p13.33-13.2(chr12:173787-11553849)x3 ()
🧬 CCND2: NM_001759.4(CCND2):c.806_818dup (p.Glu274fs) ()
🧬 CCND2: NM_001759.4(CCND2):c.416_419dup (p.Leu141fs) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 1,047 variantes classificadas pelo ClinVar.

157
209
681
Patogênica (15.0%)
VUS (20.0%)
Benigna (65.0%)
VARIANTES MAIS SIGNIFICATIVAS
DNMT3A: NM_022552.5(DNMT3A):c.1425_1426del (p.Glu477fs) [Pathogenic]
NFIX: NM_001365902.3(NFIX):c.170dup (p.Asp58fs) [Likely pathogenic]
NFIX: NM_001365902.3(NFIX):c.232_262del (p.Lys78fs) [Pathogenic]
DNMT3A: NM_022552.5(DNMT3A):c.176C>T (p.Pro59Leu) [Uncertain significance]
DNMT3A: NM_022552.5(DNMT3A):c.2251T>C (p.Phe751Leu) [Uncertain significance]

Vias biológicas (Reactome)

170 vias biológicas associadas aos genes desta condição.

Cyclin D associated events in G1 Regulation of RUNX1 Expression and Activity Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) Drug-mediated inhibition of CDK4/CDK6 activity Glycosaminoglycan-protein linkage region biosynthesis HS-GAG biosynthesis HS-GAG degradation Defective B4GALT7 causes EDS, progeroid type Defective B3GAT3 causes JDSSDHD Defective EXT2 causes exostoses 2 Defective EXT1 causes exostoses 1, TRPS2 and CHDS Defective B3GALT6 causes EDSP2 and SEMDJL1 Attachment and Entry Retinoid metabolism and transport Respiratory syncytial virus (RSV) attachment and entry RSV-host interactions Dengue Virus-Host Interactions Dengue Virus Attachment and Entry Antigen processing: Ubiquitination & Proteasome degradation Regulation of gene expression in beta cells Nuclear Receptor transcription pathway Nephron development Signaling by BRAF and RAF1 fusions The fatty acid cycling model Synthesis of PIPs at the plasma membrane Synthesis of IP3 and IP4 in the cytosol Negative regulation of the PI3K/AKT network Downstream TCR signaling TP53 Regulates Metabolic Genes PTEN Loss of Function in Cancer Ub-specific processing proteases Ovarian tumor domain proteases Regulation of PTEN mRNA translation Regulation of PTEN localization Regulation of PTEN stability and activity Transcriptional Regulation by MECP2 Transcriptional activation of mitochondrial biogenesis Citric acid cycle (TCA cycle) Mitochondrial protein degradation Maturation of TCA enzymes and regulation of TCA cycle Platelet degranulation Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) IRS-related events triggered by IGF1R SHC-related events triggered by IGF1R Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) PKMTs methylate histone lysines Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate NADPH regeneration Neutrophil degranulation Peroxisomal protein import NFE2L2 regulating TCA cycle genes ATP sensitive Potassium channels Regulation of insulin secretion Defective ABCC8 can cause hypo- and hyper-glycemias PRC2 methylates histones and DNA Oxidative Stress Induced Senescence SUMOylation of chromatin organization proteins Activation of anterior HOX genes in hindbrain development during early embryogenesis Regulation of PTEN gene transcription Transcriptional Regulation by E2F6 HCMV Early Events Defective pyroptosis Negative Regulation of CDH1 Gene Transcription Regulation of PD-L1(CD274) transcription Regulation of PLK1 Activity at G2/M Transition Loss of Nlp from mitotic centrosomes Recruitment of mitotic centrosome proteins and complexes Loss of proteins required for interphase microtubule organization from the centrosome Recruitment of NuMA to mitotic centrosomes Hedgehog 'off' state Anchoring of the basal body to the plasma membrane AURKA Activation by TPX2 Basigin interactions Proton-coupled monocarboxylate transport Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) Aspirin ADME Defective GCK causes maturity-onset diabetes of the young 2 (MODY2) Defective HK1 causes hexokinase deficiency (HK deficiency) FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes Activation of BAD and translocation to mitochondria PIP3 activates AKT signaling Downregulation of ERBB2:ERBB3 signaling AKT phosphorylates targets in the cytosol AKT phosphorylates targets in the nucleus AKT-mediated inactivation of FOXO1A CD28 dependent PI3K/Akt signaling Co-inhibition by CTLA4 G beta:gamma signalling through PI3Kgamma VEGFR2 mediated vascular permeability Constitutive Signaling by AKT1 E17K in Cancer Regulation of TP53 Degradation Regulation of TP53 Activity through Acetylation Regulation of TP53 Activity through Association with Co-factors Cyclin E associated events during G1/S transition Cyclin A:Cdk2-associated events at S phase entry RAB GEFs exchange GTP for GDP on RABs RUNX2 regulates genes involved in cell migration FLT3 Signaling Regulation of localization of FOXO transcription factors Estrogen-dependent nuclear events downstream of ESR-membrane signaling KEAP1-NFE2L2 pathway SARS-CoV-2 targets host intracellular signalling and regulatory pathways Transcriptional and post-translational regulation of MITF-M expression and activity ABC-family proteins mediated transport Ion homeostasis Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome Post-translational protein phosphorylation Translocation of SLC2A4 (GLUT4) to the plasma membrane Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation MTOR signalling eNOS activation Integrin signaling Deactivation of the beta-catenin transactivating complex Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA KSRP (KHSRP) binds and destabilizes mRNA Interleukin-4 and Interleukin-13 signaling PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 Z-decay: degradation of maternal mRNAs by zygotically expressed factors RNA Polymerase III Transcription Termination RNA Polymerase III Abortive And Retractive Initiation Glutamate and glutamine metabolism MicroRNA (miRNA) biogenesis Small interfering RNA (siRNA) biogenesis tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis M-decay: degradation of maternal mRNAs by maternally stored factors Regulation of MITF-M-dependent genes involved in apoptosis PI3K Cascade IRS-mediated signalling GPVI-mediated activation cascade Interleukin-7 signaling Signaling by SCF-KIT Downstream signal transduction PI3K/AKT activation Signaling by ALK Role of phospholipids in phagocytosis Tie2 Signaling Constitutive Signaling by Aberrant PI3K in Cancer DAP12 signaling Role of LAT2/NTAL/LAB on calcium mobilization Nephrin family interactions G alpha (q) signalling events VEGFA-VEGFR2 Pathway Interleukin-3, Interleukin-5 and GM-CSF signaling RAF/MAP kinase cascade RET signaling RHOA GTPase cycle Extra-nuclear estrogen signaling RHOB GTPase cycle CDC42 GTPase cycle RAC1 GTPase cycle RAC2 GTPase cycle Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants PI3K events in ERBB4 signaling GAB1 signalosome Signaling by cytosolic FGFR1 fusion mutants PI3K events in ERBB2 signaling Constitutive Signaling by EGFRvIII PI-3K cascade:FGFR1 PI-3K cascade:FGFR2 PI-3K cascade:FGFR3 PI-3K cascade:FGFR4 Activation of AKT2 PDE3B signalling Inhibition of TSC complex formation by PKB Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA Beta oxidation of octanoyl-CoA to hexanoyl-CoA Beta oxidation of hexanoyl-CoA to butanoyl-CoA Beta oxidation of butanoyl-CoA to acetyl-CoA

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
Aprovado1
3Fase 32
2Fase 210
1Fase 11
·Pré-clínico11
Medicamentos catalogadosEnsaios clínicos· 9 medicamentos · 16 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome de supercrescimento

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

4 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

19 ensaios clínicos encontrados, 7 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
350 papers (10 anos)
#1

Familial pneumothorax in twins with Tatton-Brown-Rahman DNMT3A overgrowth syndrome.

European journal of human genetics : EJHG2026 Feb 25

Spontaneous pneumothorax is a common respiratory presentation that may signal underlying genetic disease. Familial pneumothorax occurs in ~10% of primary cases, yet 75% remain genetically unclassified. We report identical twin brothers presenting with spontaneous pneumothoraces in adulthood, leading to a diagnosis of Tatton-Brown-Rahman syndrome (TBRS), a DNMT3A-related overgrowth disorder not previously associated with pneumothorax. Both individuals exhibited tall stature, mild intellectual disability, hypermobility, and cardiac abnormalities. Whole genome sequencing identified a rare de novo DNMT3A missense variant (c.1585 G > A, p.D529N) absent from population databases and predicted to be damaging. Methylation profiling confirmed genome-wide hypomethylation consistent with impaired DNMT3A function, supporting pathogenicity. No variants were found in known familial pneumothorax genes. Apical blebs observed at surgery and connective tissue features suggest a mechanistic link between TBRS and pneumothorax, analogous to other monogenic connective tissue disorders. This case expands the phenotypic spectrum of TBRS and highlights the importance of genetic evaluation in familial pneumothorax. Diagnosis enables personalised care, including surveillance for extrapulmonary complications such as aortic root dilatation and haematological malignancy. Our findings suggest that TBRS should be considered in patients presenting with pneumothorax, tall stature, and neurodevelopmental features. Further cases are needed to confirm this association and refine clinical management strategies.

#2

A More Precise Description of the AKT2-Related Hypoinsulinemic Hypoglycemia and Overgrowth Syndrome Phenotype, Formerly Described Under the MORFAN Acronym.

American journal of medical genetics. Part A2026 Mar 23

The AKT2-related hypoinsulinemic hypoglycemia and overgrowth syndrome was initially described over 30 years ago as MORFAN syndrome which was an acronym for Mental retardation, pre- and post-natal Overgrowth, Remarkable Face, and Acanthosis Nigricans. Despite the limited possibility of confirming a diagnosis on the molecular level at that time, a comprehensive 30-year follow-up of a patient facilitated a detailed exploration of the syndrome's clinical trajectory. This article presents a case report spanning three decades, highlighting the significance of detailed clinical follow-up in understanding and studying this unique syndrome. Although initially associated with intellectual deficiency, the patient's intellectual abilities remain largely within the normal range. Neuropsychological examinations revealed selective neurocognitive impairment, with a predominant disruption in psychomotor speed and executive functions. Molecular genetic examination confirmed a pathogenic variant in the AKT2 gene, associated with impaired insulin metabolism and increased tumorigenesis risk. Neurooncological assessments revealed intracranial meningiomatosis, emphasizing the syndrome's potential oncological implications. Surgical interventions addressed various complications, including meningiomas and renal hamartomas. The presented case offers valuable insights into the long-term natural history of AKT2-related hypoinsulinemic hypoglycemia and overgrowth syndrome, suggesting the importance of regular oncological surveillance due to its predisposition to tumorigenesis, thereby providing clinical considerations for future cases based on long-term follow-up experience.

#3

Transvenous biopsy of body cistyc lesions in a 32-year-old man with cloves syndrome and thrombocytopenia: a safe option for high bleeding risk patients.

CVIR endovascular2026 Mar 18

Image guided percutaneous biopsy is a standard in interventional radiology but can be limited by anatomical or clinical factors. Alternative techniques, such as transvenous biopsy, can aid in cases with these constraints, particularly in patients with thrombocytopenia. A 32-year-old male with PIK3CA related overgrowth syndrome presenting as Congenital, Lipomatous, Overgrowth, Vascular malformations, Epidermal nevi, Spinal/skeletal anomalies and/or scoliosis (CLOVES) syndrome, was admitted to the emergency department with bleeding cystic lesions and severe thrombocytopenia. The initial medical approach for patients with thrombocytopenia must be supported by a genetic or histopathologic examination, as required by insurance protocols. Percutaneous fine-needle biopsy often has low diagnostic yield in such cases. Due to the high risk of bleeding associated with thrombocytopenia and the vascular nature of the cystic lesions, direct percutaneous biopsy was contraindicated. Instead, a transvenous biopsy was performed by accessing the lesion through a venous route under image guidance, allowing for safe tissue sampling without the risk of significant hemorrhage. This approach confirmed PIK3CA involvement and guided subsequent treatment. Transvenous biopsy serves as a safe and effective alternative to standard percutaneous biopsy in high-risk patients with thrombocytopenia and vascular lesions, enabling accurate diagnosis while minimizing bleeding complications.

#4

SPIN4-related X-linked overgrowth in a family.

European journal of medical genetics2026 Mar 02

Spindlin Family Member 4 (SPIN4) is an epigenetic reader gene on the X chromosome. Its loss-of-function variant altering the WNT/β-catenin pathway was recently reported to cause a SPIN4-associated overgrowth syndrome in an extended family. The index case is a 14-year-old male with tall stature (+2.0 SD) as the only growth-related finding, accompanied by protruding joints, splenomegaly, low bone mineral density, and normal intelligence. Exome sequencing identified the same loss-of-function variant of SPIN4 (NM_001012968.3:c.312_313del:p.(Arg104Serfs*24)), which was identified in the original family. The variant was present in the proband's mother and maternal grandmother. They both had skewed X-deviation (80% and 20%) and no height gain to their mid-parental heights. The first patient with the same SPIN4 variant described by Lui et al. had more pronounced birth weight and height compared to our patient, and an advanced bone age by one year. Both patients exhibited tall stature, normal pubertal timing, psychomotor development, and intellect, as well as similar facial features and organomegaly (Lui et al., 2023).

#5

Macrocephaly and Characteristic MRI Findings as Early Clues to a Hereditary Overgrowth Syndrome.

Cureus2026 Jan

Macrocephaly may be the presenting feature of underlying genetic conditions in childhood. We report a five-year-old boy with persistent macrocephaly above +3 standard deviations since infancy and subtle facial dysmorphisms. Neurological examination revealed hypotonia, a wide-based gait, and fine and gross motor difficulties. Developmental assessment confirmed psychomotor delay without features of autism spectrum disorder. Brain MRI revealed multiple enlarged perivascular spaces involving the bilateral subcortical white matter and the corpus callosum, as well as callosal thickening. Genetic testing identified a heterozygous likely pathogenic variant in the PTEN gene, with maternal transmission confirmed on familial testing. Timely genetic diagnosis allows appropriate genetic counselling and clinical follow-up.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC156 artigos no totalmostrando 198

2026

A More Precise Description of the AKT2-Related Hypoinsulinemic Hypoglycemia and Overgrowth Syndrome Phenotype, Formerly Described Under the MORFAN Acronym.

American journal of medical genetics. Part A
2026

Transvenous biopsy of body cistyc lesions in a 32-year-old man with cloves syndrome and thrombocytopenia: a safe option for high bleeding risk patients.

CVIR endovascular
2026

SPIN4-related X-linked overgrowth in a family.

European journal of medical genetics
2026

Familial pneumothorax in twins with Tatton-Brown-Rahman DNMT3A overgrowth syndrome.

European journal of human genetics : EJHG
2026

Macrocephaly and Characteristic MRI Findings as Early Clues to a Hereditary Overgrowth Syndrome.

Cureus
2026

Functional evaluation of pancreatic islets from patients with Beckwith-Wiedemann syndrome and congenital hyperinsulinism.

The Journal of clinical endocrinology and metabolism
2026

Effectiveness of the low FODMAP diet in patients with irritable bowel syndrome and small intestine bacterial overgrowth syndrome.

Frontiers in nutrition
2026

Genetic diagnosis of macrotia in PIK3CA-Related Overgrowth Spectrum (PROS) and long-term outcome of otoplasty: a case report and literature review.

Brazilian journal of otorhinolaryngology
2025

Convergent DNA methylation abnormalities at enhancers and bivalent promoters in human growth disorders.

Epigenetics & chromatin
2025

Tatton-Brown-Rahman Syndrome Due to a Novel DNMT3A Variant Presenting With Autism, Attention-Deficit/Hyperactivity Disorder (ADHD), and Regression: A Saudi Case Report.

Cureus
2025

From Overgrowth to Complex Malformations: A Novel EZH2 Variant Reveals the Expanding Clinical Spectrum of Weaver Syndrome.

Children (Basel, Switzerland)
2026

Clinicopathologic Characterization of Liver Biopsies of Patients with Congenital Hyperinsulinism Presenting with Neonatal Cholestasis.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society
2025

Beckwith-Wiedemann syndrome and large offspring syndrome involve alterations in methylome, transcriptome, and chromatin configuration.

NAR molecular medicine
2025

Clinical and Molecular Evaluation of Beckwith-Wiedemann Syndrome with the BWSICS Score.

Molecular syndromology
2026

Recurrent platelet-derived growth factor receptor beta gene mutations in Kosaki overgrowth syndrome: a molecular and clinical overview.

Clinical dysmorphology
2025

Helicobacter pylori infection as a risk factor in the development of metabolic dysfunction-associated steatotic liver disease.

World journal of hepatology
2026

Drug repurposing in PIK3CA-related overgrowth spectrum: breakthroughs from overgrowth syndromes to kidney disease.

Kidney international
2025

Clinical Observation of a Rare Binder Phenotype With Fetal Overgrowth Due to a SPIN4 Mutation.

Maternal-fetal medicine (Wolters Kluwer Health, Inc.)
2025

Variable response of germline activating PDGFRB variants to receptor tyrosine kinase inhibitors: implications for treatment.

European journal of human genetics : EJHG
2025

Neurodevelopmental and Neurologic Manifestations of PTEN Hamartoma Tumor Syndrome: Management Recommendations.

Neurology. Genetics
2025

Haploinsufficiency of Runx2 restores the cranial sutures in a mouse model of Pdgfrb-related craniosynostosis.

Human molecular genetics
2025

A Previously Unreported Bilateral Condylar Hyperplasia as a Manifestation of Luscan-Lumish Syndrome.

The Journal of craniofacial surgery
2025

A Prenatal Ultrasound Study of Cerebral Cortical Sulci and Gyri Development in Fetuses With Overgrowth Syndrome and/or Cerebral Malformations due to Abnormalities in MTOR Pathway Genes.

Molecular genetics & genomic medicine
2025

[Prevalence and risk of small intestinal bacterial overgrowth in patients with rosacea: A systematic review and meta-analysis].

Terapevticheskii arkhiv
2025

Tatton-Brown-Rahman-Syndrome-associated DNMT3A mutations de-repress cortical interneuron differentiation to disrupt neuronal network function.

bioRxiv : the preprint server for biology
2025

[The influence of dietary pattern on the production of volatile organic compounds in patients with hydrogen-producing small intestinal bacterial overgrowth syndrome].

Voprosy pitaniia
2025

[Small intestinal bacterial overgrowth in gastrointestinal diseases - a consequence or a cause of progression?].

Voprosy pitaniia
2025

Somatic PIK3R1 mutations in the iSH2 domain are accessible to PI3Kα inhibition.

EMBO molecular medicine
2025

Single-nucleus multiomic analysis of Beckwith-Wiedemann syndrome liver reveals PPARA signaling enrichment and metabolic dysfunction.

Communications biology
2025

Approach to Macrodactyly: A Case Report and Diagnostic Algorithm for Syndromic and Isolated Forms.

Pediatric reports
2025

Management, Trends, and Recommendations for Intra-abdominal Lymphatic Malformations: A Single-Center Retrospective Review.

Journal of pediatric surgery
2025

Cancer and Overgrowth Manifestations of PTEN Hamartoma Tumor Syndrome: Management Recommendations from the International PHTS Consensus Guidelines Working Group.

Clinical cancer research : an official journal of the American Association for Cancer Research
2024

Uncovering somatic mosaic variants of PIK3CA-related overgrowth disorders - three cases with different clinical presentations.

Frontiers in genetics
2025

Fixed dosing of alpelisib for children with vascular anomalies: Can we do better?

British journal of clinical pharmacology
2025

Dysmorphic syndromes with overgrowth - systematic review.  Part 1 - monogenic syndromes.

Pediatric endocrinology, diabetes, and metabolism
2025

Cancer and disease profiles for PTEN pathogenic variants in Japanese population.

Journal of human genetics
2025

DNMT3A-related overgrowth syndrome presenting with immune thrombocytopenic purpura.

Current research in translational medicine
2024

The ileocecal valve in transabdominal ultrasound Part 1: Sonographic anatomy and technique.

Journal of ultrasonography
2024

A Patient Case of Malan Syndrome Involving 19p13.2 Deletion of NFIX with Longitudinal Follow-Up and Future Prospectives.

Journal of clinical medicine
2025

Klippel-Trénaunay-Weber Syndrome: Prenatal Diagnosis and Review of the Literature.

Journal of clinical ultrasound : JCU
2024

[Therapeutic and diagnostic complex in intestinal failure syndrome in patients with closed abdominal trauma].

Khirurgiia
2024

Behavioral Changes in a Pediatric Patient With Sotos Syndrome: A Case Emphasizing the Importance of Coordinated Care.

Cureus
2024

Venous Anomalies in Overgrowth Syndromes.

Techniques in vascular and interventional radiology
2024

Genetic insights into the mechanisms of proliferative glomerulonephritis.

The Journal of clinical investigation
2024

Natural history in Malan syndrome: survey of 28 adults and literature review.

Orphanet journal of rare diseases
2024

A cystic and bullous lung disease associated with a PIK3CA-related overgrowth syndrome.

ERJ open research
2024

Type 1 Diabetes in a Pediatric Patient With Beckwith-Wiedemann Syndrome.

JCEM case reports
2024

Overgrowth Disorders: A Case of Sotos Syndrome and Overview of Related Disorders.

South Dakota medicine : the journal of the South Dakota State Medical Association
2024

Electrical Status Epilepticus during Sleep in a Male Filipino with Rare Nonsense Mutation Variant of Sotos Syndrome on Carbamazepine Monotherapy.

Acta medica Philippina
2024

Expanding the genetic and clinical spectrum of Tatton-Brown-Rahman syndrome in a series of 24 French patients.

Journal of medical genetics
2025

Common questions and rationale answers about the intestinal bacterial overgrowth syndrome (SIBO).

Gastroenterologia y hepatologia
2024

Atypical Presentation and Evolution of Necrotizing Enterocolitis as a PIK3CA Pathological Variant.

Cureus
2024

Surgical Management of Overgrowth Syndrome With Bilateral Vision-Threatening Ptosis.

Ophthalmic plastic and reconstructive surgery
2024

GestaltMML: Enhancing Rare Genetic Disease Diagnosis through Multimodal Machine Learning Combining Facial Images and Clinical Texts.

ArXiv
2024

A de novo Mutation (p.Gln277X) of Cyclin D2 is Responsible for a Child with Megalencephaly-Polymicrogyria-Polydactyly-Hydrocephalus Syndrome.

DNA and cell biology
2024

Clinical phenotype of the PIK3R1-related vascular overgrowth syndrome.

The British journal of dermatology
2024

Skeletal abnormalities in mice with Dnmt3a missense mutations.

Bone
2024

Combined surgery and sclerotherapy for 13 years: a case report of a patient with CLOVES.

Frontiers in pediatrics
2024

Megalencephaly secondary to a novel germline missense variant p.Asp322Tyr in AKT3 associated with growth hormone deficiency and central hypothyroidism: A case report.

American journal of medical genetics. Part A
2024

Simpson-Golabi-Behmel syndrome type 1 with normal birth parameters.

BMJ case reports
2024

PIK3CA-Related Disorders: From Disease Mechanism to Evidence-Based Treatments.

Annual review of genomics and human genetics
2024

Development of disease-specific growth charts for Korean children with Beckwith-Wiedemann syndrome.

Clinical genetics
2024

Syndromic and single gene disorders associated with fetal megacystis (I): Megacystis-microcolon-intestinal hypoperistalsis syndrome (MMIHS).

Taiwanese journal of obstetrics & gynecology
2024

Chromosomal abnormalities associated with fetal megacystis.

Taiwanese journal of obstetrics & gynecology
2023

DIS3L2 Gene Mutation Causes the Perlman Syndrome of Overgrowth and Wilms Tumor Susceptibility.

Cureus
2024

Neurogastroenterology and Motility Disorders of the Gastrointestinal Tract in Cystic Fibrosis.

Current gastroenterology reports
2024

IL-22 is secreted by proximal tubule cells and regulates DNA damage response and cell death in acute kidney injury.

Kidney international
2023

Sotos syndrome treated with traditional Chinese medicine and rehabilitation: Case report.

Medicine
2024

An adult patient with Tatton-Brown-Rahman syndrome caused by a novel DNMT3A variant and axonal polyneuropathy.

American journal of medical genetics. Part A
2023

Early is Better: Report of a Cowden Syndrome.

Global medical genetics
2024

Molecular characterization of 13 patients with PIK3CA-related overgrowth spectrum using a targeted deep sequencing approach.

American journal of medical genetics. Part A
2023

[Genetic analysis of a Chinese pedigree affected with overgrowth syndrome due to a small supernumerary marker chromosome].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2024

New cases of recently described Thauvin-Robinet-Faivre syndrome with a novel homozygous FIBP gene variant.

American journal of medical genetics. Part A
2024

Tatton-Brown-Rahman syndrome: Novel pathogenic variants and new neuroimaging findings.

American journal of medical genetics. Part A
2024

Pediatric cancer incidence among individuals with overgrowth syndromes and overgrowth features: A population-based assessment in seven million children.

Cancer
2023

Case report: Progressive pulmonary artery hypertension in a case of megalencephaly-capillary malformation syndrome.

Frontiers in genetics
2023

[Clinical phenotype and genetic analysis of a patient with a heterozygous 6p25.3 deletion and partial trisomy 15q].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2023

Beckwith-Wiedemann syndrome in a child with multifocal Wilms tumor and lateralized overgrowth: A case report.

Radiology case reports
2024

High Prevalence of Small Intestinal Bacterial Overgrowth Syndrome in ICU Patients: An Observational Study.

Journal of intensive care medicine
2023

Vascular Anomalies Care in the United States: A Cross-Sectional National Survey.

The Journal of pediatrics
2023

IL-22 promotes acute kidney injury through activation of the DNA damage response and cell death in proximal tubule cells.

bioRxiv : the preprint server for biology
2023

Report on a Case with Moreno-Nishimura-Schmidt Overgrowth Syndrome: A Clinically Delineated Disease Yet of an Unknown Origin!

Molecular syndromology
2023

Expanding the phenotype and genotype in Thauvin-Robinet-Faivre syndrome: A new patient with a novel variant and additional clinical findings.

American journal of medical genetics. Part A
2023

Melanoma in a patient with DNMT3A overgrowth syndrome.

Cold Spring Harbor molecular case studies
2023

Contemporary management of extracranial vascular malformations.

Pediatric radiology
2023

Simultaneous presence of Brugada and overgrowth syndromes.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace
2023

Cognitive, adaptive and behavioral profile in Sotos syndrome children with 5q35 microdeletion or intragenic variants.

American journal of medical genetics. Part A
2024

CDKN1C -Related Beckwith-Wiedemann Syndrome: First Patient from India.

Journal of pediatric genetics
2023

Prevalence of Small Intestinal Bacterial Overgrowth Syndrome in Patients with Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis: A Cross-Sectional Study.

Microorganisms
2022

Ultrasound diagnosis of syndromic cases with vascular malformations and soft tissue overgrowth: A rare case of CLOVES syndrome.

Ultrasound (Leeds, England)
2023

Loss-of-function variant in SPIN4 causes an X-linked overgrowth syndrome.

JCI insight
2024

Subdural Hemorrhage as an Early Presentation in a Case of Sotos Syndrome.

Neuropediatrics
2023

Sociodemographic characteristics of pediatric patients with vascular malformations: Results of a single site study.

Frontiers in pediatrics
2023

A rare case of Klippel-Trenaunay syndrome presenting with chronic myeloid leukemia.

The Turkish journal of pediatrics
2023

Treatment of Primary Hyperparathyroidism in the Setting of Tatton-Brown-Rahman Syndrome.

The American surgeon
2023

Imagawa-Matsumoto syndrome: SUZ12-related overgrowth disorder.

Clinical genetics
2022

Highly sensitive liquid biopsy Duplex sequencing complements tissue biopsy to enhance detection of clinically relevant genetic variants.

Frontiers in oncology
2022

Personality, Anxiety, and Stress in Patients with Small Intestine Bacterial Overgrowth Syndrome. The Polish Preliminary Study.

International journal of environmental research and public health
2022

PIK3CA gain-of-function mutation in adipose tissue induces metabolic reprogramming with Warburg-like effect and severe endocrine disruption.

Science advances
2022

Muscle hemihypertrophy syndrome with PIK3CA gene mutation associated with Tourette syndrome.

JAAD case reports
2022

Differentially expressed tRNA-derived fragments in bovine fetuses with assisted reproduction induced congenital overgrowth syndrome.

Frontiers in genetics
2022

Gastrointestinal toxicity of systemic oncology immunotherapy.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
2022

Early diagnosis of Malan syndrome in an infant presenting with macrocephaly.

BMJ case reports
2022

[Diabetic gastroenteropathy: modern methods of diagnosis and treatment].

Problemy endokrinologii
2022

A Rare Case of an Asymmetric Overgrowth Syndrome in a Kenyan African Child: A Case Report and Review of Literature.

Cureus
2022

Vascular Anomaly Syndromes in the ISSVA Classification System: Imaging Findings and Role of Interventional Radiology in Management.

Radiographics : a review publication of the Radiological Society of North America, Inc
2022

Clinical and genetic analyses of patients with lateralized overgrowth.

BMC medical genomics
2022

Early diagnosis enabling precision medicine treatment in a young boy with PIK3R1-related overgrowth.

European journal of medical genetics
2022

Mediating and maintaining methylation while minimizing mutation: Recent advances on mammalian DNA methyltransferases.

Current opinion in structural biology
2022

[Tatton-Brown-Rahman Syndrome: Case report and DNMT3A variant not previously reported associated to the syndrome].

Andes pediatrica : revista Chilena de pediatria
2023

Undergrowth Of First Toe In PiK3CA-Related Overgrowth Spectrum (PROS).

Annals of vascular surgery
2022

Use of intercostal nerve block for chest wall pain in a patient with CLOVES syndrome.

Pain management
2022

Postmortem Diagnosis of the Proteus Syndrome by Next Generation Sequencing of Affected Brain Tissue.

Academic forensic pathology
2022

Monochorionic twins with 15q26.3 duplication presenting with selective intrauterine growth restriction and discordant cardiac anomalies: A case report.

Molecular genetics & genomic medicine
2022

Severe small intestinal bacterial overgrowth syndrome after jejunal feeding requiring surgical intervention: a case report and review of the literature.

BMC gastroenterology
2022

Penttinen syndrome-associated PDGFRB Val665Ala variant causes aberrant constitutive STAT1 signalling.

Journal of cellular and molecular medicine
2022

Brain overgrowth associated with megalencephaly-capillary malformation syndrome causing progressive Chiari and syringomyelia.

Surgical neurology international
2022

The Role of Interventional Pain Management in Proteus Syndrome: A Case Report.

Cureus
2022

Somatic non-cancerous overgrowth syndrome of obscure molecular etiology: what are the causes and options?

Journal of molecular medicine (Berlin, Germany)
2022

[Assessment of the state of the small intestine microbiota in children on a long-term dairy-free diet].

Voprosy pitaniia
2022

Spontaneous and ART-induced large offspring syndrome: similarities and differences in DNA methylome.

Epigenetics
2022

A Review on Cutaneous and Musculoskeletal Manifestations of CLOVES Syndrome.

Clinical, cosmetic and investigational dermatology
2022

The Klippel-Trénaunay Syndrome in 2022: Unravelling Its Genetic and Molecular Profile and Its Link to the Limb Overgrowth Syndromes.

Vascular health and risk management
2022

Small integral membrane protein 10 like 1 downregulation enhances differentiation of adipose progenitor cells.

Biochemical and biophysical research communications
2022

Kosaki Overgrowth Syndrome: Report of a Family with a Novel PDGFRB Variant.

Molecular syndromology
2022

Case Report: Primary Pleural Angiosarcoma in a Patient With Klippel-Trenaunay Syndrome.

Frontiers in genetics
2022

Alpelisib to treat CLOVES syndrome, a member of the PIK3CA-related overgrowth syndrome spectrum.

British journal of clinical pharmacology
2022

Hedgehog pathway modulation by glypican 3-conjugated heparan sulfate.

Journal of cell science
2022

Activating PIK3CA postzygotic mutations in segmental overgrowth of muscles with bone involvement in the body extremities.

Molecular genetics and genomics : MGG
2022

Simpson-Golabi-Behmel syndrome in one of the Dichorionic-diamniotic twin: a case report and literature review.

BMC pregnancy and childbirth
2022

Glioblastoma in Beckwith-Wiedemann syndrome: first case report and review of potential pathomechanisms.

Acta neurochirurgica
2021

New Metabolic, Digestive, and Oxidative Stress-Related Manifestations Associated with Posttraumatic Stress Disorder.

Oxidative medicine and cellular longevity
2022

Surprising genetic and pathological findings in a patient with giant bilateral periadrenal tumours: PEComas and mutations of PTCH1 in Gorlin-Goltz syndrome.

Journal of medical genetics
2021

Acquired Hyperzincaemia Due to Zinc-Laden Denture Adhesives Leading to Hypocupraemia as a Cause of Neutropenia.

European journal of case reports in internal medicine
2021

Quantitative DNA Methylation Analysis and Epigenotype-Phenotype Correlations in Taiwanese Patients with Beckwith-Wiedemann Syndrome.

Journal of personalized medicine
2021

Macrodystrophia Lipomatosa: A Rare Cause of Bilateral Lower Limb Gigantism.

Cureus
2023

Approach to clinically significant vascular anomalies in children.

Singapore medical journal
2022

DNMT3A overgrowth syndrome is associated with the development of hematopoietic malignancies in children and young adults.

Blood
2021

Skeletal stem cell fate defects caused by Pdgfrb activating mutation.

Development (Cambridge, England)
2021

Acute Coronary Syndrome Requiring Coronary Artery Bypass Grafting in a Patient With Sotos Syndrome.

JACC. Case reports
2022

Kosaki overgrowth syndrome due to a novel de novo PDGFRB variant.

Clinical genetics
2022

Aortic root dilatation and dilated cardiomyopathy in an adult with Tatton-Brown-Rahman syndrome.

American journal of medical genetics. Part A
2021

[Perlman syndrome research progress].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2021

Beckwith-Wiedemann syndrome: Clinical, histopathological and molecular study of two Tunisian patients and review of literature.

Molecular genetics & genomic medicine
2021

[Chronic intestinal pseudoobstruction: difficulties in diagnosis and treatment. Case report].

Terapevticheskii arkhiv
2021

Sotos syndrome with a novel mutation in the NSD1 gene associated with congenital hypothyroidism.

International journal of pediatrics & adolescent medicine
2021

Functional and epigenetic phenotypes of humans and mice with DNMT3A Overgrowth Syndrome.

Nature communications
2021

Telomerase Dysfunction in the Tumorigenesis of Genetic Disorders.

International journal of molecular and cellular medicine
2021

A review of mechanisms of disease across PIK3CA-related disorders with vascular manifestations.

Orphanet journal of rare diseases
2021

PIK3CA-related overgrowth spectrum: animal model and drug discovery.

Comptes rendus biologies
2021

Wilms tumour surveillance in at-risk children: Literature review and recommendations from the SIOP-Europe Host Genome Working Group and SIOP Renal Tumour Study Group.

European journal of cancer (Oxford, England : 1990)
2021

Non-hotspot PIK3CA mutations are more frequent in CLOVES than in common or combined lymphatic malformations.

Orphanet journal of rare diseases
2021

Sotos syndrome: a pitfall in the presurgical workup of temporal lobe epilepsy.

Epileptic disorders : international epilepsy journal with videotape
2021

Positive response to imatinib in PDGFRB-related Kosaki overgrowth syndrome.

American journal of medical genetics. Part A
2021

Phenotype and Surgical Treatment in a Case of Proteus Syndrome With Craniofacial and Oral Findings.

In vivo (Athens, Greece)
2021

Pharmacological and cell-specific genetic PI3Kα inhibition worsens cardiac remodeling after myocardial infarction.

Journal of molecular and cellular cardiology
2021

Dnmt3a deficiency in the skin causes focal, canonical DNA hypomethylation and a cellular proliferation phenotype.

Proceedings of the National Academy of Sciences of the United States of America
2020

[Prevalence of small bowel bacterial overgrowth in patients with functional dyspepsia: a meta-analysis].

Terapevticheskii arkhiv
2021

[The role of intraepithelial lymphocytes in pathogenesis of small intestinal bacterial overgrowth syndrome].

Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego
2021

Segmental overgrowth and aneurysms due to mosaic PDGFRB p.(Tyr562Cys).

American journal of medical genetics. Part A
2021

Clinical experience with the AKT1 inhibitor miransertib in two children with PIK3CA-related overgrowth syndrome.

Orphanet journal of rare diseases
2021

[The importance of the bacterial overgrowth syndrome in the development of disorders metabolic functions of the liver in non-alcoholic fatty liver disease].

Terapevticheskii arkhiv
2021

Simpson-Golabi-Behmel-Syndrome in Dichorionic-Diamniotic Twin Pregnancy.

Clinics and practice
2020

Impact of the Synbiotics and Urate-Lowering Therapy on Gut Microbiota and Cytokine Profile in Patients with Chronic Gouty Arthritis.

Journal of medicine and life
2021

PDGF receptor mutations in human diseases.

Cellular and molecular life sciences : CMLS
2021

Somatic non-cancerous PIK3CA-related overgrowth syndrome treated with alpelisib in North America.

Journal of molecular medicine (Berlin, Germany)
2021

Progressive cerebral and coronary aneurysms in the original two patients with Kosaki overgrowth syndrome.

American journal of medical genetics. Part A
2021

A Case of Luscan-Lumish Syndrome: Possible Involvement of Enhanced GH Signaling.

The Journal of clinical endocrinology and metabolism
2020

Clinical Profile of Overgrowth Syndromes Consistent with PROS (PIK3CA-Related Overgrowth Syndromes)-A Case Series.

Indian dermatology online journal
2021

A boy with Silver-Russell syndrome and Sotos syndrome.

American journal of medical genetics. Part A
2020

Molecular analysis of a uterine broad ligament leiomyoma in a patient with CLOVES syndrome.

Pathology, research and practice
2020

A novel microgravity postural rehabilitation protocol in Beckwith Wiedemann syndrome: a case report.

La Clinica terapeutica
2021

pn-Heterojunction of the SWCNT/ZnO nanocomposite for temperature dependent reaction with hydrogen.

Journal of colloid and interface science
2021

Small Intestinal Bacterial Overgrowth Syndrome: A Guide for the Appropriate Use of Breath Testing.

Digestive diseases and sciences
2021

High Prevalence of Small Intestinal Bacterial Overgrowth among Functional Dyspepsia Patients.

Digestive diseases (Basel, Switzerland)
2020

Gingival Biopsy to Detect Mosaicism in Overgrowth Syndromes: Report of Two Cases of Megalencephaly-Capillary Malformation Syndrome with Periodontal Anomalies.

Case reports in dentistry
2020

[Innovative approaches to study food patterns in functional gastrointestinal disorders].

Voprosy pitaniia
2020

Carpal tunnel syndrome in paediatric patients: A novel association with Kosaki overgrowth syndrome.

JPRAS open
2020

[Association of thermal food processing methods and small intestinal bacterial overgrowth syndrome].

Voprosy pitaniia
2020

Genetics of Neonatal Hypoglycaemia.

Pediatric endocrinology reviews : PER
2020

Coexistence of paternally-inherited ABCC8 mutation and mosaic paternal uniparental disomy 11p hyperinsulinism.

International journal of pediatric endocrinology
2020

Megalencephaly-Capillary Malformation-Polymicrogyria with Cerebral Venous Thrombosis.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
2020

Cantú syndrome versus Zimmermann-Laband syndrome: Report of nine individuals with ABCC9 variants.

European journal of medical genetics
2020

[Evaluation of the effectiveness of differentiated therapy of non-alcoholic fatty liver disease].

Terapevticheskii arkhiv
2019

[Association of food patterns with different forms of small intestinal bacterial overgroth syndrome and treatment efficacy].

Terapevticheskii arkhiv
2019

[Non - alcoholic fatty liver disease and enteral insufficiency: comorbidity of their development].

Terapevticheskii arkhiv
2020

Diffuse infantile hepatic hemangiomas in a patient with Beckwith-Wiedemann syndrome: A new association?

American journal of medical genetics. Part A
2020

Activating variants in PDGFRB result in a spectrum of disorders responsive to imatinib monotherapy.

American journal of medical genetics. Part A
2020

The importance of lactose intolerance in individuals with gastrointestinal symptoms.

Revista de gastroenterologia de Mexico (English)
2020

Phenotype and growth in Sotos syndrome patient from DR Congo (Central Africa).

American journal of medical genetics. Part A
2020

PIK3CA-Related Overgrowth Syndrome (PROS) and Angiosarcoma: A Case Report.

Eplasty
2020

Kosaki overgrowth syndrome: A novel pathogenic variant in PDGFRB and expansion of the phenotype including cerebrovascular complications.

Clinical genetics
2020

Drug repositioning for rare diseases: Knowledge-based success stories.

Therapie
2020

A familial case of overgrowth syndrome caused by a 9q22.3 microdeletion in a mother and daughter.

European journal of medical genetics
2020

One of the First Cases with PIK3CA-related Overgrowth Spectrum (PROS) in Saudi Arabia: A Case Report and Literature Review.

Cureus
2020

DNA methylation analysis of multiple imprinted DMRs in Sotos syndrome reveals IGF2-DMR0 as a DNA methylation-dependent, P0 promoter-specific enhancer.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
2019

First identified Korean family with Tatton-Brown-Rahman Syndrome caused by the novel DNMT3A variant c.118G>C p.(Glu40Gln).

Annals of pediatric endocrinology & metabolism
2019

Case Report: Occupational therapy in a patient with an overgrowth syndrome that restricts movement.

F1000Research

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome de supercrescimento.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome de supercrescimento

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Familial pneumothorax in twins with Tatton-Brown-Rahman DNMT3A overgrowth syndrome.
    European journal of human genetics : EJHG· 2026· PMID 41741684mais citado
  2. A More Precise Description of the AKT2-Related Hypoinsulinemic Hypoglycemia and Overgrowth Syndrome Phenotype, Formerly Described Under the MORFAN Acronym.
    American journal of medical genetics. Part A· 2026· PMID 41869744mais citado
  3. Transvenous biopsy of body cistyc lesions in a 32-year-old man with cloves syndrome and thrombocytopenia: a safe option for high bleeding risk patients.
    CVIR endovascular· 2026· PMID 41849068mais citado
  4. SPIN4-related X-linked overgrowth in a family.
    European journal of medical genetics· 2026· PMID 41780720mais citado
  5. Macrocephaly and Characteristic MRI Findings as Early Clues to a Hereditary Overgrowth Syndrome.
    Cureus· 2026· PMID 41717203mais citado
  6. Connective tissue growth in a mouse model of Kosaki overgrowth syndrome is limited by STAT1.
    bioRxiv· 2026· PMID 41993315recente
  7. Identification of Modified Histones as Binding Substrates of Human Spindlin Family Member 4 (SPIN4) by Peptide Arrays and Native Nucleosome Pulldown.
    J Vis Exp· 2026· PMID 41973624recente
  8. Phenotype Expansion of Malan Syndrome: New Cases and a Review of the Literature.
    Am J Med Genet A· 2026· PMID 41930635recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:93460(Orphanet)
  2. MONDO:0019716(MONDO)
  3. GARD:19213(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q7113674(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Síndrome de supercrescimento
Compêndio · Raras BR

Síndrome de supercrescimento

ORPHA:93460 · MONDO:0019716
CID-10
Q87.3 · Síndromes com malformações congênitas com hipercrescimento precoce
CID-11
Ensaios
7 ativos
Medicamentos
9 registrados
MedGen
UMLS
C2986703
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades